普瑞眼科
(301239)
| 流通市值：29.23亿 | | | 总市值：61.78亿 |
| 流通股本：7078.95万 | | | 总股本：1.50亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 551,793,599.46 | 481,067,596.27 | 479,822,198.29 | 511,778,507.9 |
| 应收票据及应收账款 | 134,907,501.85 | 101,080,594.08 | 100,681,983.67 | 122,423,147.59 |
| 应收账款 | 134,907,501.85 | 101,080,594.08 | 100,681,983.67 | 122,423,147.59 |
| 预付款项 | 7,665,569.5 | 12,043,865.27 | 26,780,003.54 | 20,995,348.51 |
| 其他应收款合计 | 80,088,101.73 | 72,400,392.46 | 95,314,008.45 | 84,248,732.87 |
| 存货 | 165,816,396.6 | 148,312,611.64 | 162,949,240.82 | 163,904,209.31 |
| 一年内到期的非流动资产 | 1,231,087.37 | 617,520.95 | - | - |
| 其他流动资产 | 40,590,155.53 | 33,643,149.73 | 32,393,925.08 | 26,308,763.19 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,042,289,047.66 | 869,259,065.91 | 1,054,000,620.13 | 1,065,125,051.83 |
| 非流动资产: | | | | |
| 长期应收款 | 22,462,203.27 | 22,791,618.7 | - | - |
| 长期股权投资 | 169,770,786.45 | 170,089,374.5 | 115,665,871.33 | 117,225,105.54 |
| 固定资产 | 1,224,460,521.66 | 1,250,098,693.11 | 1,130,266,928.17 | 1,081,841,779.42 |
| 在建工程 | 14,385,378.77 | 53,140,470.08 | 98,681,114.27 | 79,152,646.16 |
| 使用权资产 | 1,230,681,718.27 | 1,265,516,176.22 | 1,326,059,339.53 | 1,437,487,222.33 |
| 无形资产 | 45,569,090.97 | 46,729,700.02 | 47,815,373.98 | 49,046,314.96 |
| 商誉 | 419,395,958.13 | 407,575,727.97 | 391,999,028.87 | 391,999,028.87 |
| 长期待摊费用 | 506,499,004.13 | 487,597,095.94 | 510,051,461.95 | 520,089,188.81 |
| 递延所得税资产 | 21,037,831.23 | 20,728,869.89 | 20,272,383.02 | 21,680,896.93 |
| 其他非流动资产 | 499,867 | 4,499,932 | 11,049,034.98 | 55,549,750.6 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,654,762,359.88 | 3,728,767,658.43 | 3,651,860,536.1 | 3,754,071,933.62 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,697,051,407.54 | 4,598,026,724.34 | 4,705,861,156.23 | 4,819,196,985.45 |
| 流动负债: | | | | |
| 短期借款 | 140,991,937.93 | 158,987,898.29 | 89,040,592.34 | 48,400,000 |
| 应付票据及应付账款 | 302,606,513.17 | 249,878,971.24 | 320,731,431.32 | 286,988,201.76 |
| 应付账款 | 302,606,513.17 | 249,878,971.24 | 320,731,431.32 | 286,988,201.76 |
| 预收款项 | - | 0 | - | - |
| 合同负债 | 21,394,361.16 | 16,985,480.51 | 21,757,627.6 | 21,781,632.03 |
| 应付职工薪酬 | 120,368,951.68 | 141,107,637.21 | 138,432,965.83 | 119,634,403.57 |
| 应交税费 | 40,101,982.49 | 35,634,640.4 | 37,273,591.26 | 41,079,021.06 |
| 其他应付款合计 | 92,729,857.43 | 107,334,155.72 | 36,235,689.37 | 53,461,517.95 |
| 一年内到期的非流动负债 | 197,493,086.99 | 189,159,024.37 | 141,710,663.79 | 193,275,423.21 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 915,686,690.85 | 899,087,807.74 | 785,182,561.51 | 764,620,199.58 |
| 非流动负债: | | | | |
| 长期借款 | 395,217,505.07 | 345,365,294.08 | 364,552,603.84 | 335,486,436.82 |
| 租赁负债 | 1,225,913,428.21 | 1,229,714,221.38 | 1,302,005,981.73 | 1,380,379,500.05 |
| 递延收益 | 207,968.82 | 242,074.8 | - | - |
| 递延所得税负债 | 2,452,349.25 | 2,451,724.42 | 2,408,107.16 | 2,464,811.99 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,623,791,251.35 | 1,577,773,314.68 | 1,668,966,692.73 | 1,718,330,748.86 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,539,477,942.2 | 2,476,861,122.42 | 2,454,149,254.24 | 2,482,950,948.44 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 149,619,048 | 149,619,048 | 149,619,048 | 149,619,048 |
| 资本公积 | 1,742,187,019.42 | 1,736,264,206.78 | 1,735,326,760.56 | 1,735,326,760.56 |
| 减:库存股 | 59,770,175.6 | 59,770,175.6 | 59,770,175.6 | 59,770,175.6 |
| 其他综合收益 | -139,101.86 | -139,101.86 | -285,711.93 | -285,711.93 |
| 盈余公积 | 49,603,541.8 | 49,603,541.8 | 44,637,522.07 | 44,637,522.07 |
| 未分配利润 | 253,199,390.4 | 225,920,033.77 | 348,589,379.72 | 435,588,178.33 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,134,699,722.16 | 2,101,497,552.89 | 2,218,116,822.82 | 2,305,115,621.43 |
| 少数股东权益 | 22,873,743.18 | 19,668,049.03 | 33,595,079.17 | 31,130,415.58 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,157,573,465.34 | 2,121,165,601.92 | 2,251,711,901.99 | 2,336,246,037.01 |
| 负债和股东权益合计 | 4,697,051,407.54 | 4,598,026,724.34 | 4,705,861,156.23 | 4,819,196,985.45 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |